Delivery Order SPE2DR25D2005-SPE2DR26FE9B0
- Not listed
- The Defense Logistics Agency issued a delivery order valued at $8,234.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 (a combination inhalation powder for chronic obstructive pulmonary disease treatment) on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency awarded a $1,456.86 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination inhalation medication used to treat chronic obstructive pulmonary disease). This firm fixed-price delivery order, with an ultimate completion date of November 28, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $14,531.57 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units), a combination respiratory medication used primarily in chronic obstructive pulmonary disease management. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $4,036.34 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,351.01 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 10, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $9,493.59 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count supply). This competitively awarded, firm fixed-price delivery order was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,140.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $23,626.87 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price contract has an ultimate completion date of December 18, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $32,431.82 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents...
- The Defense Logistics Agency awarded a delivery order valued at $8,046.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The award, issued December 1, 2025, with completion targeted for December 2, 2025, was made on a firm fixed-price basis without set-aside restrictions, indicating competitive award through open procurement. This delivery order is a child contract under AmerisourceBergen's...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE9B0Delivery Order
The Defense Logistics Agency awarded a $8,590.31 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count unit), a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a critical role in the federal medical supply chain, serving military and veteran healthcare systems through the Defense Logistics Agency. As the prime contractor on this delivery order, the company leverages its comprehensive pharmaceutical distribution capabilities to support the Defense Health Agency and other federal healthcare programs. The contract received no set-aside designation, demonstrating AmerisourceBergen's competitive standing in open federal procurement processes for pharmaceutical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 12/16/25 |